Session information

Symposium

[SY08] Symposium 8　Recent advances in targeted therapy for B-cell malignancies
【E】

Thu. Feb 17, 2022 3:50 PM - 5:20 PM Room 7 (Room E, 1F, Kyoto International Conference Center)

Chair：Shinsuke Iida（Department of Hematology and Oncology, Nagoya City University），Dai Maruyama（Department of Hematology Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research）

+Add all to schedule

[SY08-1] Recent advances in chimeric antigen receptor T-cell therapy

^○Dai Chihara (Department of Lymphoma and Myeloma, MD Anderson Cancer Center)

[SY08-2] The development of BCR signaling pathway-targeted therapy for B-cell malignancies

^○Wataru Munakata (Department of Hematology, National Cancer Center Hospital)

[SY08-3] Recent advances in targeted therapy for B-cell malignancies

^○Miguel A Canales (Department of Hematology, La Paz University Hospital)

[SY08-4] CD38-targeted therapy for multiple myeloma: Mechanisms of action and clinical development

^○Akihiro Kitadate (Department of Hematology, Nephrology, and Rheumatology, Akita University)

[SY08-5] Action mechanisms of BCMA -targeted therapies for multiple myeloma and their promising and exciting clinical results in relapse/refractory patients

^○Yoichi Imai (Department of Hematology and Oncology, IMSUT Hospital, The Institute of Medical Science, The University of Tokyo)

▲